Encouraging preliminary results in 12 patients with high-risk haematological malignancies by omitting graft-versus-host disease prophylaxis after allogeneic transplantation

British Journal of Haematology

Volumn 111, Issue 2, 2000, Pages 662-667

  Roman, Jose ^a   Parziale, Adele ^b   Gottardi, Enrico ^b   De Micheli, Daniela ^b   Cilloni, Daniela ^b   Tiribelli, Mario ^c   Gonzalez, Maria Gracia ^a   Rodriguez, Maria Del Carmen ^a   Torres, Antonio ^a   Saglio, Giuseppe ^b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

Allogeneic bone marrow transplantation; Graft versus host disease prophylaxis; High risk malignancies; Omission

Indexed keywords

ASPARAGINASE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; INTERFERON; MELPHALAN; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; RETINOIC ACID; TACROLIMUS; THYMOCYTE ANTIBODY; TOPOTECAN; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CAUSE OF DEATH; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LARGE CELL LYMPHOMA; LEUKEMIA; LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; REMISSION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ACUTE DISEASE; ADULT; BONE MARROW TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAFT VS HOST DISEASE; GRAFT VS TUMOR EFFECT; HUMANS; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, T-CELL, ACUTE; LYMPHOMA, B-CELL; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PILOT PROJECTS; PREDNISONE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034529960     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02363.x     Document Type: Article

References (17)

1. Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant
2. The graft-versus-leukemia effect
3. Controlled graft-versus-host reaction in the treatment of leukemia in mice
4. Graft versus leukemia in bone marrow transplantation
5. Time pattern of the antileukemic effect of graft-versus-host reaction
6. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
7. Paradigm shift for graft versus host disease
8. Clinical manifestations of acute graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
9. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation
10. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation
11. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
12. Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients
13. Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation
14. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms
15. Graft versus leukemia
16. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: A multicenter randomized trial from the Italian group for bone marrow transplantation
17. Graft-vs-leukemia effect in clinical bone marrow transplantation